Who are Avidity Biosciences, Inc.'s main suppliers?

Avidity Biosciences, Inc. (RNAM) key suppliers include: Dyne Therapeutics, Inc., Keros Therapeutics, Inc., Entrada Therapeutics, Inc.. View the full supplier network at chainsifter.com/chain/RNAM.

Who are Avidity Biosciences, Inc.'s major customers?

Avidity Biosciences, Inc. (RNAM) key customers include: Dyne Therapeutics, Inc., Keros Therapeutics, Inc., Entrada Therapeutics, Inc.. View the full customer network at chainsifter.com/chain/RNAM.

What sector is Avidity Biosciences, Inc. in?

Avidity Biosciences, Inc. (RNAM) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

RNAM Supply Chain: Avidity Biosciences, Inc. Supplier List & 6 Relationships

3Suppliers

3Customers

0Debt Items

20Related Chains

Avidity Biosciences, Inc. Suppliers

Ticker	Name	Confidence	Evidence
DYN	Dyne Therapeutics, Inc.	72%	Reciprocal relationship from DYN graph: ces and our business and operations, including clinical trials, could be disrupted by any problems with our significant third-party vendors. We engage a number…
KROS	Keros Therapeutics, Inc.	72%	Reciprocal relationship from KROS graph: Reciprocal relationship from RNAM graph: Reciprocal relationship from KROS graph: nued regulatory review, which may result in significant additional expense a…
TRDA	Entrada Therapeutics, Inc.	72%	Reciprocal relationship from TRDA graph: Reciprocal relationship from RNAM graph: Reciprocal relationship from TRDA graph: f treatment with our therapeutics in relation to alternative treatments and …

Avidity Biosciences, Inc. Customers

Ticker	Name	Confidence	Evidence
DYN	Dyne Therapeutics, Inc.	72%	Reciprocal relationship from DYN graph: that the FORCE platform achieved delivery to the CNS. Intravenous, or IV, administration of FORCE conjugate, our proprietary Fab antibody conjugated to an ASO,…
KROS	Keros Therapeutics, Inc.	72%	Reciprocal relationship from KROS graph: nued regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirement…
TRDA	Entrada Therapeutics, Inc.	72%	Reciprocal relationship from TRDA graph: everal risks, including disruptions in supply, price increases or late deliveries. There are, in general, relatively few alternative sources of supply for sub…

Avidity Biosciences, Inc. Debt Obligations

No debt relationships on recordNo publicly disclosed debt instruments or credit facilities found for Avidity Biosciences, Inc..

Avidity Biosciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Avidity Biosciences, Inc..

Avidity Biosciences, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Avidity Biosciences, Inc..

Avidity Biosciences, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
CPRX	Catalyst Pharmaceuticals, Inc.	100.00	2
DSGN	Design Therapeutics, Inc.	100.00	2
BCYC	Bicycle Therapeutics plc	100.00	2
DYN	Dyne Therapeutics, Inc.	100.00	2	['customer', 'supplier']
CAPR	Capricor Therapeutics, Inc.	100.00	2
REGN	Regeneron Pharmaceuticals, Inc.	100.00	2
EWTX	Edgewise Therapeutics, Inc.	100.00	2
ALNY	Alnylam Pharmaceuticals, Inc.	100.00	2
BMRN	BioMarin Pharmaceutical Inc.	100.00	2
ARWR	Arrowhead Pharmaceuticals, Inc.	100.00	2
BMY	Bristol-Myers Squibb Company	100.00	2
BMYMP	Bristol-Myers Squibb Co	100.00	2
IONS	Ionis Pharmaceuticals, Inc.	100.00	2
PEPG	PepGen Inc.	100.00	1	['spend']
WVE	Wave Life Sciences Ltd.	100.00	2
VRTX	Vertex Pharmaceuticals Incorporated	100.00	2
IBIO	iBio, Inc.	100.00	2
TKPHF	Takeda Pharmaceutical Company Limited	100.00	2
TRDA	Entrada Therapeutics, Inc.	100.00	1	['customer', 'supplier']
MYGN	Myriad Genetics, Inc.	100.00	2

Avidity Biosciences, Inc. Supply Chain